While Larimar Therapeutics Inc has underperformed by -0.55%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, LRMR rose by 79.78%, with highs and lows ranging from $13.68 to $2.18, whereas the simple moving average fell by -3.08% in the last 200 days.
On September 04, 2024, Robert W. Baird started tracking Larimar Therapeutics Inc (NASDAQ: LRMR) recommending Outperform. A report published by Leerink Partners on April 03, 2024, Initiated its previous ‘Outperform’ rating for LRMR. Citigroup also Upgraded LRMR shares as ‘Buy’, setting a target price of $4.50 on the company’s shares in a report dated November 17, 2023. Guggenheim Initiated an Buy rating on October 19, 2022, and assigned a price target of $12. William Blair February 15, 2022d its ‘Outperform’ rating to ‘Mkt Perform’ for LRMR, as published in its report on February 15, 2022. William Blair also rated the stock as ‘Outperform’.
Analysis of Larimar Therapeutics Inc (LRMR)
In order to gain a clear picture of Larimar Therapeutics Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -37.48% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 10.93, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 506.60K can be a very valuable indicator of volatility for LRMR stock. On a monthly basis, the volatility of the stock is set at 8.52%, whereas on a weekly basis, it is put at 10.06%, with a loss of -10.56% over the past seven days. Furthermore, long-term investors anticipate a median target price of $22.14, showing growth from the present price of $7.20, which can serve as yet another indication of whether LRMR is worth investing in or should be passed over.
How Do You Analyze Larimar Therapeutics Inc Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 41.58%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 62.83% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
LRMR shares are owned by institutional investors to the tune of 62.83% at present.
